|
|
||||||||
Journal of Lipid Research, Vol 36, 1866-1875, Copyright © 1995 by Lipid Research, Inc.
RA Zoeller, MD Layne and EJ Modest
We have isolated two mutant strains from the murine, macrophage-like cell
line, RAW 264.7, that are resistant to the cytotoxic effects of the
antineoplastic, platelet activating factor analogue, 1-octadecyl-2-
methyl-rac-glycero-3-phosphocholine (ET-18-OMe). The mutants were isolated
using a single round of selection to ensure that resistance was due to a
single gene defect. These mutants, RAW.R1 and RAW.R23, are approximately 20
times more resistant to ET-18-OMe (ID50 = 15-17 microM) than the parent
strain (ID50 = 0.7-1.0 microM). Resistance to ET-18-OMe was due to a 90-95%
reduction in the ability to take up and accumulate this compound. The
uptake of other choline glycerophospholipids (e.g., platelet activating
factor and 1-acyl-2- lyso-sn-glycero-3-phosphocholine) was also severely
affected. This defect was not limited to choline glycerophospholipids; the
uptake of an ethanolamine glycerophospholipid (1-alkyl-2-lyso-sn-glycero-3-
phosphoethanolamine) was reduced by 80%. The uptake of palmitic acid, an
amphipathic molecule bearing no phosphate-containing head group, was
unaffected in the mutants. There was little metabolism of ET-18-OMe by
either the wild-type or mutant cells. Binding of ET-18-OMe appeared to be
normal in the mutants, but internalization of pre-bound ET-18-OMe was
reduced. Uptake of non-lipid ligands such as horseradish peroxidase,
lucifer yellow, and transferrin was normal in the mutants demonstrating
that fluid-phase and receptor-mediated endocytosis is functional. The
ability to generate mutants displaying a lesion that affects the uptake of
both choline and ethanolamine phospholipids demonstrates that these species
are internalized by RAW cells through one common primary route or through
pathways that share a common factor. These mutants, and this approach to
their isolation, offer a system with which to study and define the
mechanisms of glycerophospholipid uptake into macrophages as well as other
cell types.
ARTICLES
Animal cell mutants unable to take up biologically active glycerophospholipids
Department of Biophysics, Boston University School of Medicine, MA 02118, USA.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
F. J. Perez-Victoria, F. Gamarro, M. Ouellette, and S. Castanys Functional Cloning of the Miltefosine Transporter: A NOVEL P-TYPE PHOSPHOLIPID TRANSLOCASE FROM LEISHMANIA INVOLVED IN DRUG RESISTANCE J. Biol. Chem., December 12, 2003; 278(50): 49965 - 49971. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Perez-Victoria, S. Castanys, and F. Gamarro Leishmania donovani Resistance to Miltefosine Involves a Defective Inward Translocation of the Drug Antimicrob. Agents Chemother., August 1, 2003; 47(8): 2397 - 2403. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. H. van der Luit, M. Budde, P. Ruurs, M. Verheij, and W. J. van Blitterswijk Alkyl-lysophospholipid Accumulates in Lipid Rafts and Induces Apoptosis via Raft-dependent Endocytosis and Inhibition of Phosphatidylcholine Synthesis J. Biol. Chem., October 11, 2002; 277(42): 39541 - 39547. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Perez-Victoria, F. J. Perez-Victoria, A. Parodi-Talice, I. A. Jimenez, A. G. Ravelo, S. Castanys, and F. Gamarro Alkyl-Lysophospholipid Resistance in Multidrug-Resistant Leishmania tropica and Chemosensitization by a Novel P-Glycoprotein-Like Transporter Modulator Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2468 - 2474. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Baburina and S. Jackowski Apoptosis Triggered by 1-O-Octadecyl-2-O-methyl-rac-glycero-3-phosphocholine Is Prevented by Increased Expression of CTP:Phosphocholine Cytidylyltransferase J. Biol. Chem., January 23, 1998; 273(4): 2169 - 2173. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |